mTORinhibitor-26 (Compound HPT-11) is an mTOR inhibitor with an IC50 of 0.7 nM. It effectively inhibits the proliferation of AML cell lines Molm-13 and MV-4-11. mTORinhibitor-26 exhibits antitumor activity and demonstrates good metabolic stability, making it promising for research in the field of cancer.
Target:
mTOR
* VAT and and shipping costs not included. Errors and price changes excepted
